Acquired disorders of haemostasis: pathophysiology, clinical practice and basic researchMICHIELS, Jan J.Baillière's clinical haematology. 1998, Vol 11, Num 2, issn 0950-3536, 244 p.Serial Issue

Regulation of nitrogen fixation in Rhizobium leguminosarum biovar phaseoli CNPAF512: a structural and functional analysis of nif and fix genesMICHIELS, Jan.Dissertationes de agricultura. 1994, Num 244, issn 0772-1285, 157 p.Thesis

Recombinant factor VIII products and hemophilia A: efficacy, safety, and inhibitor developmentMICHIELS, Jan J.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 3, issn 0094-6176, 85 p.Serial Issue

Strategies in the diagnosis of deep vein thrombosis and pulmonary embolism. Part 2MICHIELS, Jan Jacques.Seminars in thrombosis and hemostasis. 2001, Vol 27, Num 1, issn 0094-6176, 58 p.Serial Issue

Recombinant activated factor VII (rFVIIa): from concept to clinical utilityMICHIELS, Jan Jacques.Seminars in thrombosis and hemostasis. 2000, Vol 26, Num 4, issn 0094-6176, 80 p.Serial Issue

New developments in diagnosis and management of venous thromboembolismMICHIELS, Jan Jacques.Seminars in thrombosis and hemostasis. 1998, Vol 24, Num 4, issn 0094-6176, 114 p.Serial Issue

Platelet-dependent vascular complications and bleeding symptoms in essential thrombocythemia and polycythemia vera, Part IMICHIELS, Jan J.Seminars in thrombosis and hemostasis. 1997, Vol 23, Num 4, issn 0094-6176, 76 p.Serial Issue

Platelet-dependent vascular complications and bleeding symptoms in essential thrombocythemia and polycythemia vera, part IIMICHIELS, Jan J.Seminars in thrombosis and hemostasis. 1997, Vol 23, Num 5, issn 0094-6176, 84 p.Serial Issue

The role of JAK2 V617F mutation, spontaneous erythropoiesis and megakaryocytopoiesis, hypersensitive platelets, activated leukocytes, and endothelial cells in the etiology of thrombotic manifestations in polycythemia vera and essential thrombocythemiaBELLUCCI, Sylvia; MICHIELS, Jan J.Seminars in thrombosis and hemostasis. 2006, Vol 32, Num 4, pp 381-398, issn 0094-6176, 18 p.Article

Acquired von Willebrand syndrome: Experience from 2 years in a single laboratory compared with data from the literature and an International RegistryBUDDE, Ulrich; BERGMANN, Frauke; MICHIELS, Jan J et al.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 2, pp 227-237, issn 0094-6176Article

Recombinant FVIIa in the treatment of warfarin bleedingBERNTORP, Erik.Seminars in thrombosis and hemostasis. 2000, Vol 26, Num 4, pp 433-435, issn 0094-6176Article

Rhizobial secreted proteins as determinants of host specificity in the rhizobium-legume symbiosisFAUVART, Maarten; MICHIELS, Jan.FEMS microbiology letters. 2008, Vol 285, Num 1, pp 1-9, issn 0378-1097, 9 p.Article

The anticoagulant potential of the protein C system in hereditary and acquired thrombophilia : Pathomechanisms and new tools for assessing its clinical relevanceKRAUS, M.Seminars in thrombosis and hemostasis. 1998, Vol 24, Num 4, pp 337-354, issn 0094-6176Article

Hemophilia and von Willebrand disease in developing countriesSRIVASTAVA, Alok; MICHIELS, Jan J.Seminars in thrombosis and hemostasis. 2005, Vol 31, Num 5, issn 0094-6176, 125 p.Serial Issue

The use of recombinant factor VIII products in previously treated patients with hemophilia A: Pharmacokinetics, efficacy, safety, and inhibitor developmentLEE, Christine.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 3, pp 241-246, issn 0094-6176Article

New characteristics of anti-factor VIII inhibitor antibody epitopes and unusual immune responses to factor VIIISCANDELLA, Dorothea.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 3, pp 291-296, issn 0094-6176Article

Noninvasive diagnosis of deep vein thrombosis in postoperative patientsKEARON, Clive.Seminars in thrombosis and hemostasis. 2001, Vol 27, Num 1, pp 3-8, issn 0094-6176Article

Pharmacokinetics of Recombinant activated factor VII (rFVIIa)ERHARDTSEN, Elisabeth.Seminars in thrombosis and hemostasis. 2000, Vol 26, Num 4, pp 385-391, issn 0094-6176Article

Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitorsINGERSLEV, Jørgen.Seminars in thrombosis and hemostasis. 2000, Vol 26, Num 4, pp 425-432, issn 0094-6176Article

Part 2: Essential Thrombocythemia and Polycythemia Vera: Diagnosis, Pathophysiology and ManagementMICHIELS, Jan J; GRIESSHAMMER, Martin.Seminars in thrombosis and hemostasis. 2006, Vol 32, Num 4, issn 0094-6176, 140 p.Serial Issue

Clinical and pathological criteria for the diagnosis of essential thrombocythemia, Polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia)MICHIELS, Jan Jacques; THIELE, Juergen.International journal of hematology. 2002, Vol 76, Num 2, pp 133-145, issn 0925-5710, 13 p.Article

Effectiveness of the recombinant factor VIIa in patients with the coagulopathy of advanced child's B and C cirrhosisBERNSTEIN, David.Seminars in thrombosis and hemostasis. 2000, Vol 26, Num 4, pp 437-438, issn 0094-6176Article

Thrombotic thrombocytopenic purpura : diagnosis, pathogenesis and modern therapyELDOR, A.Baillière's clinical haematology. 1998, Vol 11, Num 2, pp 475-495, issn 0950-3536Article

Aspirin resistance : Does it exist?RAO, Gundu H. R; MICHIELS, Jan Jaques.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 2, pp 210-214, issn 0094-6176, 5 p.Article

Treatment of polycythemia veraSILVER, Richard T.Seminars in thrombosis and hemostasis. 2006, Vol 32, Num 4, pp 437-442, issn 0094-6176, 6 p.Article